top of page

The Hormone Dilemma: Navigating the Controversies of HRT

For women experiencing menopause, the symptoms can be uncomfortable and debilitating. Hot flashes, night sweats, and mood swings are just a few of the symptoms that can make life difficult. However, hormone replacement therapy (HRT) can provide significant relief from these symptoms and offer a range of other benefits as well. Not only is HRT an effective means of mitigating these symptoms, it also provides an avenue to reduce risk of osteoporosis, cardiovascular disease, dementia, and even certain cancers. Unfortunately, HRT has fell out of favor in modern medicine ever since the WHI trial was published in 2002, which misrepresented data that led to fear in the public eye.


Let's take a few minutes to dig into this because trust me, it's important!


The WHI trial consisted of two arms: one testing estrogen alone, and the other testing a combination of estrogen and progestin. The trial was stopped early after researchers found an increased risk of breast cancer, heart disease, and stroke in the combination arm. However, the risks were small, and the benefits of HRT were not emphasized in the media coverage of the trial.


One of the main issues with the coverage of the WHI trial is that the risks were presented as absolute numbers rather than relative risks. For example, the increased risk of breast cancer in the combination arm was reported as a 26% increase. However, this increase represents a relative risk, meaning that the risk of breast cancer in the combination arm was 1.26 times higher than the risk in the placebo arm. In absolute terms, this means that for every 10,000 women taking the combination therapy for one year, there would be eight additional cases of breast cancer compared to the placebo group. This is a small increase in risk, and it is important to consider the potential benefits of HRT as well.


In addition, the WHI trial enrolled women who were on average 63 years old and 10 years postmenopausal, which is not representative of the majority of women who start HRT around the time of menopause. Not only this, but these women also had a higher prevalence of pre-existing conditions such as heart disease, high blood pressure, and high cholesterol, which may have influenced the results of the study. Women who start HRT early in menopause are more likely to experience benefits such as a reduced risk of heart disease and osteoporosis.


Furthermore, the WHI trial used a specific type of progestin (medroxyprogesterone acetate), which has been associated with an increased risk of breast cancer. Other types of progestins may not have the same risk. Additionally, the WHI trial did not investigate the use of estrogen alone in women who have had a hysterectomy, which has been shown to have different risks and benefits than combination therapy.


The misinterpretation of the data from the WHI trial, particularly the exaggerated reporting of the risks associated with HRT, led to a widespread misunderstanding of the benefits and risks of HRT. This misunderstanding, in turn, led to a decrease in the utilization of HRT among women, particularly in the United States. The decline in HRT use was particularly dramatic in the years immediately following the release of the trial results, with many women and healthcare providers avoiding HRT altogether.


However, subsequent analyses of the trial data and the re-evaluation of the benefits and risks of HRT have led to a shift in the medical community's understanding of HRT. Many experts now agree that the risks of HRT are generally small and outweighed by the benefits, particularly for women who start HRT early in menopause, although studies now point support safety in starting some forms of HRT later in life. The decline in HRT use may have resulted in missed opportunities to improve women's health, particularly with respect to the prevention of osteoporosis, cardiovascular disease, and dementia.


I am really excited to share evidence-based information about hormone replacement therapy (HRT) with women so that they can make informed choices about their health. It's so important to have accurate information when it comes to managing menopausal symptoms and preventing chronic diseases.


I believe that every woman should have access to reliable information about HRT so that they can make well-informed decisions about their health.


I also believe that promoting healthcare autonomy and improving health outcomes go hand in hand with informed decision-making. By providing women with the tools and knowledge they need to make informed choices about HRT, we can empower them to take control of their health and wellbeing. I am passionate about supporting women in this journey towards greater healthcare autonomy and better health outcomes.


In health,

Dr. J











23 views0 comments

Comments


bottom of page